78 集

Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.
A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgical management of malignant bowel obstruction, and more.

The Lancet Gastroenterology & Hepatology in conversation with The Lancet Group

    • 健康與瘦身

Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.
A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgical management of malignant bowel obstruction, and more.

    Sanna Nybacka and Magnus Simrén on a trial of low FODMAP diets versus low carbohydrate diets in IBS

    Sanna Nybacka and Magnus Simrén on a trial of low FODMAP diets versus low carbohydrate diets in IBS

    Sanna Nybacka and Magnus Simrén (University of Gothenburg) discuss the CARIBS randomised controlled trial of a low FODMAP diet versus a low-carbohydrate diet versus pharmacological treatment in IBS.Read the full article:https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00045-1/fulltext?dgcid=buzzsprout_tlv_podcast_generic_langasContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelan...

    • 23 分鐘
    Nuru Noor on the PROFILE trial of biomarker-stratified treatment in newly diagnosed Crohn's disease

    Nuru Noor on the PROFILE trial of biomarker-stratified treatment in newly diagnosed Crohn's disease

    Nuru Noor (University of Cambridge) discusses the PROFILE trial of biomarker-stratified treatment strategies in people with newly diagnosed Crohn's disease.Read the full article:https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00034-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_langasContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/comp...

    • 19 分鐘
    Yusuke Shimakawa on a simple score for hepatitis B treatment eligibility in Africa

    Yusuke Shimakawa on a simple score for hepatitis B treatment eligibility in Africa

    Yusuke Shimakawa (Institut Pasteur) discusses the development and evaluation of a simple score for hepatitis B treatment eligibility in Africa.Read the full article:https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00449-1?dgcid=buzzsprout_icw_podcast_generic_langasContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://...

    • 20 分鐘
    Mads Israelsen on validating the new steatotic liver disease nomenclature in people with excessive alcohol intake

    Mads Israelsen on validating the new steatotic liver disease nomenclature in people with excessive alcohol intake

    Mads Israelsen (Odense University Hospital) discusses a study to validate the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake.Read the full article:https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00443-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_langasContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttp...

    • 16 分鐘
    Louise Dye on the role of expectancy and gluten in non-coeliac gluten sensitivity

    Louise Dye on the role of expectancy and gluten in non-coeliac gluten sensitivity

    Louise Dye (University of Leeds) discusses a trial exploring the role of expectancy and gluten ingestion on symptoms in people with non-coeliac gluten sensitivity.Read the full article:https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00317-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_langasContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.c...

    • 23 分鐘
    Tzu-Chan Hong on the primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region

    Tzu-Chan Hong on the primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region

    Tzu-Chan Hong (National Taiwan University Cancer Centre) discusses a systematic review and meta-analysis on primary antibiotic resistance of Helicobacter pylori between 1990 and 2022 in the Asia-Pacific region.Read the full article:https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00281-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_langasContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://faceboo...

    • 14 分鐘

熱門健康與瘦身 Podcast

聽康健
康健雜誌
蒼藍鴿的醫學通識
蒼藍鴿
Vitamind 一起冥想
Vitamind
On Purpose with Jay Shetty
iHeartPodcasts
女人想聽的事What Women Want
Winnie & Royal
烏烏陪你聊
烏烏醫師、宜蘭

你可能也會喜歡

Gut Podcast
BMJ Group
American Journal of Gastroenterology Author Podcasts
American College of Gastroenterology
Evidence-Based GI: An ACG Publication and Podcast
American College of Gastroenterology
The Clinical Problem Solvers
The Clinical Problem Solvers
Core IM | Internal Medicine Podcast
Core IM Team
The Curbsiders Internal Medicine Podcast
The Curbsiders Internal Medicine Podcast